SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Extended search

WFRF:(Casanova JL)
 

Search: WFRF:(Casanova JL) > Etzioni A > Manry J > Autoantibodies agai...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Autoantibodies against type I IFNs in patients with critical influenza pneumonia

Zhang, Q (author)
Pizzorno, A (author)
Miorin, L (author)
show more...
Bastard, P (author)
Gervais, A (author)
Le Voyer, T (author)
Bizien, L (author)
Manry, J (author)
Rosain, J (author)
Philippot, Q (author)
Goavec, K (author)
Padey, B (author)
Cupic, A (author)
Laurent, E (author)
Saker, K (author)
Vanker, M (author)
Sarekannu, K (author)
Garcia-Salum, T (author)
Ferres, M (author)
Le Corre, N (author)
Sanchez-Cespedes, J (author)
Balsera-Manzanero, M (author)
Carratala, J (author)
Retamar-Gentil, P (author)
Abelenda-Alonso, G (author)
Valiente, A (author)
Tiberghien, P (author)
Zins, M (author)
Debette, S (author)
Meyts, I (author)
Haerynck, F (author)
Castagnoli, R (author)
Notarangelo, LD (author)
Gonzalez-Granado, LI (author)
Dominguez-Pinilla, N (author)
Andreakos, E (author)
Triantafyllia, V (author)
Rodriguez-Gallego, C (author)
Sole-Violan, J (author)
Ruiz-Hernandez, JJ (author)
Rodriguez de Castro, F (author)
Ferreres, J (author)
Briones, M (author)
Wauters, J (author)
Vanderbeke, L (author)
Feys, S (author)
Kuo, CY (author)
Lei, WT (author)
Ku, CL (author)
Tal, G (author)
Etzioni, A (author)
Hanna, S (author)
Fournet, T (author)
Casalegno, JS (author)
Queromes, G (author)
Argaud, L (author)
Javouhey, E (author)
Rosa-Calatrava, M (author)
Cordero, E (author)
Aydillo, T (author)
Medina, RA (author)
Kisand, K (author)
Puel, A (author)
Jouanguy, E (author)
Abel, L (author)
Cobat, A (author)
Trouillet-Assant, S (author)
Garcia-Sastre, A (author)
Casanova, JL (author)
show less...
2022-09-16
2022
English.
In: The Journal of experimental medicine. - : Rockefeller University Press. - 1540-9538 .- 0022-1007. ; 219:11
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Autoantibodies neutralizing type I interferons (IFNs) can underlie critical COVID-19 pneumonia and yellow fever vaccine disease. We report here on 13 patients harboring autoantibodies neutralizing IFN-α2 alone (five patients) or with IFN-ω (eight patients) from a cohort of 279 patients (4.7%) aged 6–73 yr with critical influenza pneumonia. Nine and four patients had antibodies neutralizing high and low concentrations, respectively, of IFN-α2, and six and two patients had antibodies neutralizing high and low concentrations, respectively, of IFN-ω. The patients’ autoantibodies increased influenza A virus replication in both A549 cells and reconstituted human airway epithelia. The prevalence of these antibodies was significantly higher than that in the general population for patients <70 yr of age (5.7 vs. 1.1%, P = 2.2 × 10−5), but not >70 yr of age (3.1 vs. 4.4%, P = 0.68). The risk of critical influenza was highest in patients with antibodies neutralizing high concentrations of both IFN-α2 and IFN-ω (OR = 11.7, P = 1.3 × 10−5), especially those <70 yr old (OR = 139.9, P = 3.1 × 10−10). We also identified 10 patients in additional influenza patient cohorts. Autoantibodies neutralizing type I IFNs account for ∼5% of cases of life-threatening influenza pneumonia in patients <70 yr old.

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view